Turkish Nephrology, Dialysis and Transplantation Journal - 1999; 8(4) http://www.tndt.org Turkish Nephrology, Dialysis and Transplantation Journal - RSS feed of 1999; 8(4) 1300-0705 September 1999 Turkish Nephrology, Dialysis and Transplantation Journal 1300-0705 <![CDATA[MARMARA DEPREMİ VE TÜRK NEFROLOJİSİ]]> http://www.tndt.org/text.php3?id=262 1999-09-01 Turkish Nephrology, Dialysis and Transplantation Journal 4 8 162 1999-09-01 158 Original Article <![CDATA[CRUSH SYNDROME and ACUTE RENAL FAILURE]]> http://www.tndt.org/text.php3?id=263 1999-09-01 Turkish Nephrology, Dialysis and Transplantation Journal 4 8 166 1999-09-01 163 Original Article <![CDATA[EFFECT OF PROTEIN INTAKE ON THE PROGRESSION OF CHRONIC RENAL FAILURE]]> http://www.tndt.org/text.php3?id=264 1999-09-01 Turkish Nephrology, Dialysis and Transplantation Journal 4 8 173 1999-09-01 167 Original Article <![CDATA[FUNGAL PERITONITIS IN PATIENTS ON CAPD]]> http://www.tndt.org/text.php3?id=265 1999-09-01 Turkish Nephrology, Dialysis and Transplantation Journal 4 8 177 1999-09-01 174 Original Article <![CDATA[PEAK EXPIRATORY FLOW AND OXYGEN SATURATION CHANGES DURING HEMODIALYSIS]]> http://www.tndt.org/text.php3?id=266 2 Sat) is reported in 5% tol5% of chronic renal failure (CRF) patients during hemodialysis (HD) procedure. Two main mechanisms have been proposed as the possible causes of this issue: on the one hand pulmonary leukostasis caused by the effecting of blood-dialysis membrane, and on the other hand, hypoventilation caused by the transfere of CO2 to acetate dialysate. Bronchoconstriction which occurs during HD has additional effect to hypoxemia. In the present study, we aimed to determine the changes of Peak Expiratory Flow (PEF) rates and the O2Sat that occur during HD and the relationship between these parameters. One hundred patients (mean age 40.38±13.12 years: range 10-67 years: 34 females, 66 males) who were in HD programme at Başkent University Hemodialysis Center between June 98 - September 98 were included in this study. The patients who develop CRF due to different etiologies were under HD programme for a period of 4 months-20 years (mean 5.04±4.2years). During dialysis, an average of 1-5 It (mean:2.87±0.8) of fluid was taken from patients. The dialysis machinary with the Cuprophan membrane and dialisate solution with bicarbonate were used during HD. The PEF rates and O2Sat were measured before dialysis and at the 30th, 60th, 180th minutes of the procedure. An increase of 1% (380-383) in the 30th and 60th minutes and 8% (383-409) in the 180th minute were observed, but there were no statistically significant differences in between them (p>0.05). Also, no significant changes were present in between the O2Sat values at the 0'", 30'", 60'", 180'" minutes of HD (p>0.05). These findings contradicts with the previous studies reported in the literature. Our results could be explained by the use of bicarbonate dialisate during HD and by taking fluids of >2lt which increase pulmonary permeability has additional positive effect in maintaining normal O 2 Sat levels.]]> 1999-09-01 Turkish Nephrology, Dialysis and Transplantation Journal 4 8 181 1999-09-01 178 Original Article <![CDATA[SHORT AND LONG TERM EFFECTS OF L-CARNITINE ON SKELETAL MUSCLE METABOLISM AND NUTRITIONAL STATUS IN DIALYZED PATIENTS]]> http://www.tndt.org/text.php3?id=267 'J9" sesta MİBİ rest scintigraphy were performed in 20 healty and in 25 patients. L-carnitine was given 2g/day for 4 months then 20-25 mg/kg/3 days a week for following 12 months in all patients. At initial, heamoglobin, hematocrite, erythrocytes and albumin, transferrin values of the patients were found lower than those of the controls, then increased during the 16 months constantly. Plasma von Willebrand Factor and creatinine, phosphate, creatine phosphocinase in serum were found higher in patients thus, decreased at the end of the L-carnitine treatment, whereas mean flbrinogene value was unchanged. In patients group, both thight and calf Tc m MİBİ uptake were found lower than those of the controls group at initial. After first six months increased, but no change was observed in following six months. Thus, suggested that carnitine have an effect on UM independently.]]> 1999-09-01 Turkish Nephrology, Dialysis and Transplantation Journal 4 8 187 1999-09-01 182 Original Article <![CDATA[FACTORS INFLUENCING PANEL REACTIVE ANTIBODY TITERS IN HEMODIALYSIS PATIENTS]]> http://www.tndt.org/text.php3?id=268 1999-09-01 Turkish Nephrology, Dialysis and Transplantation Journal 4 8 191 1999-09-01 188 Original Article <![CDATA[RESPONSIVENESS TO HEPATITIS B VACCINE IN HEMODIALYSIS, CAPD, AND PREDIALYSIS PATIENTS BY DOUBLING THE DOSE SCHEDULING]]> http://www.tndt.org/text.php3?id=269 1999-09-01 Turkish Nephrology, Dialysis and Transplantation Journal 4 8 194 1999-09-01 192 Original Article <![CDATA[IMIPENEM/CILASTATIN TREATMENT IN CAPD PERITONITIS]]> http://www.tndt.org/text.php3?id=270 1999-09-01 Turkish Nephrology, Dialysis and Transplantation Journal 4 8 199 1999-09-01 195 Original Article <![CDATA[INSULIN, LEPTİN, C-PEPTIDE AND LIPOPROTEINS EN ESSENTIAL HYPERTENSION]]> http://www.tndt.org/text.php3?id=271 1999-09-01 Turkish Nephrology, Dialysis and Transplantation Journal 4 8 205 1999-09-01 200 Original Article <![CDATA[ERYTHROCYTE MEMBRANE STIFFNESS (OR) RED CELL DEFORMABILITY, BLOOD AND PLASMA VISCOSITY IN PROTEINURIC PATIENTS]]> http://www.tndt.org/text.php3?id=272 1999-09-01 Turkish Nephrology, Dialysis and Transplantation Journal 4 8 212 1999-09-01 206 Original Article <![CDATA[OXIDATIVE STRESS AND TRACE ELEMENTS IN PROTEINURIC PATIENTS]]> http://www.tndt.org/text.php3?id=273 1999-09-01 Turkish Nephrology, Dialysis and Transplantation Journal 4 8 218 1999-09-01 213 Original Article <![CDATA[CHRONIC RENAL FAILURE DUE TO FAMILIAL HYPOMAGNESEMIC HYPERCALCIURIA (A CASE REPORT)]]> http://www.tndt.org/text.php3?id=274 1999-09-01 Turkish Nephrology, Dialysis and Transplantation Journal 4 8 220 1999-09-01 219 Case Report